Two cases of delayed diagnosis of postpartal streptococcal toxic shock syndrome

Infectious Disease in Obstetrics and Gynecology

Volumn 10, Issue 4, 2002, Pages 217-222

  Schummer, Wolfram ^a   Schummer, Claudia ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Adverse effects; Bacterial antigens; Non steroidal anti inflammatory agents; Puerperal sepsis; Streptococcal infections

Indexed keywords

BILIRUBIN; CREATININE; METRONIDAZOLE; MEZLOCILLIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; VASOACTIVE AGENT;

ANTIMICROBIAL THERAPY; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; FEMALE; FEVER; HEMODYNAMIC MONITORING; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HUMAN; HYSTERECTOMY; INTENSIVE CARE UNIT; MATERNAL MORBIDITY; MATERNAL MORTALITY; MENINGITIS; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PUERPERAL INFECTION; RUBELLA; STREPTOCOCCUS GROUP A; THROMBOCYTE COUNT; TOXIC SHOCK SYNDROME;

ADULT; APACHE; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FATAL OUTCOME; FEMALE; GERMANY; HUMANS; MALE; PREGNANCY; PUERPERAL INFECTION; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 0036997356     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1155/S106474490200025X     Document Type: Article

References (16)

1. Stevens DL. Invasive group A streptococcus infections. Clin Infect Dis 1992;14:2-11
2. Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 1996;335:547-54
3. Infection TwGoSS. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. J Am Med Assoc 1993; 269:390-1
4. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992;101:1481-3
5. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29
6. Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23:1638-52
7. Bohach GA, Fast DJ, Nelson RD, et al. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 1990;17:251-72
8. Schlievert PM. Role of superantigens in human disease. J Inject Dis 1993;167:997-1002
9. Stevens DL. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis 1995;21:977-80
10. Hackett SP, Stevens DL. Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J Infect Dis 1992;165:879-85
11. Sriskandan S, Kemball-Cook G, Moyes D, et al. Contact activation in shock caused by invasive group A Streptococcus pyogenes. Crit Care Med 2000;28:3684-91
12. Petersen EE. Streptokokken-A-Puerperalsepsis. Der Gynäkologe 1999;32:512-17
13. Stevens DL, Gibbons AE, Bergstrom R, et al. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988;158:23-8
14. Stevens DL. Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome. Clin Infect Dis 1998;26: 639-41
15. Stegmayr B, Bjorck S, Holm S, et al. Septic shock induced by group A streptococcal infection: clinical and therapeutic aspects. Scand J Infect Dis 1992;24:589-97
16. Stevens DL. Invasive group A streptococcal infections: the past, present and future. Pediatr Infect Dis J 1994;13:561-6